BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 3rd Quarter - Report

TAYLOR STRATEGIES ON BEHALF OF PTC THERAPEUTICS

via KRAMERICH POLICY STRATEGIES

3rd Quarter (July 1 - Sep 30) · 2017Posted Oct 18, 2017Filing document ↗LDA record ↗

Income$30Kfee reported

Client

Name: TAYLOR STRATEGIES ON BEHALF OF PTC THERAPEUTICS
Description: Consulting
Location: District of Columbia · United States of America

Registrant

Firm: KRAMERICH POLICY STRATEGIES
Description: Lobbying
Location: Frederick, Maryland, United States of America

Lobbying activities

1 issue

Budget/Appropriations
FDA approval process
LobbyistsLESLIE KRAMERICH
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Food & Drug Administration (FDA)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

TAYLOR STRATEGIES ON BEHALF OF PTC… — Receipts Report